← Back to Clinical Trials
Recruiting NCT04126785

NCT04126785 High-Intensity Interval Versus Moderate-Intensity Continuous Water Based Exercise in Hypertensive Older Individuals

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04126785
Status Recruiting
Phase
Sponsor Universidade Estadual Paulista Júlio de Mesquita Filho
Condition Hypertension
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2019-11-01
Primary Completion 2025-12

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
High Intensity Interval Exercise in Heated Water-BasedContinuous Moderate Exercise in Heated Water-BasedControl Group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2019-11-01 with a primary completion date of 2025-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will investigate the acute and chronic effects in hemodynamic and autonomic variables to high-intensity interval versus moderate-intensity continuous heated water-based exercise in older individuals with hypertension.

Eligibility Criteria

Inclusion Criteria: * ≥60 years old; * Hypertension diagnosed at least 6 months earlier (stage 1 or 2); * Antihypertensive drug treatment and without dosage alteration at least 3 months earlier; * Blood pressure inferior to 140/90 mmHg in medical office. Non-inclusion criteria: * Smoking individuals; * Uncontrolled cardiovascular disease; * Disability; * Deficit cognitive; Exclusion Criteria: * Non 100% participation; * Change (or stopped) clinical or drug treatment.

Contact & Investigator

Central Contact

Emmanuel Gomes G Ciolac, Phd

✉ emmanuel.ciolac@unesp.br

📞 +551431039623

Principal Investigator

Emmanuel G Ciolac, Phd

PRINCIPAL INVESTIGATOR

São Paulo State University

Frequently Asked Questions

Who can join the NCT04126785 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04126785 currently recruiting?

Yes, NCT04126785 is actively recruiting participants. Contact the research team at emmanuel.ciolac@unesp.br for enrollment information.

Where is the NCT04126785 trial being conducted?

This trial is being conducted at Bauru, Brazil.

Who is sponsoring the NCT04126785 clinical trial?

NCT04126785 is sponsored by Universidade Estadual Paulista Júlio de Mesquita Filho. The principal investigator is Emmanuel G Ciolac, Phd at São Paulo State University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology